We also found that the association between the CVRF scores and AD differed by SNP genotypes within FMNL2. FMNL2 brain expression was increased in pathological AD, with Aβ and tau deposition and with brain infarcts independently. The gene discussed is MAPT; the disease is Alzheimer disease.